An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Pharmacology

• Publication date

  2011-05-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejphar.2011.02.005PMID 21376032PMCID PMC3071461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor.

  2010cited by this paper
• Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

  2009influential reference
• Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

  2008cited by this paper
• Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition

  2008cited by this paper
• Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.

  2008cited by this paper
• A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner

  2008cited by this paper
• Reactive oxygen species involved in prenylflavonoids, icariin and icaritin, initiating cardiac differentiation of mouse embryonic stem cells

  2008cited by this paper
• The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells.

  2008cited by this paper
• A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells.

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007influential reference
• Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway.

  2007cited by this paper
• Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.

  2007cited by this paper
• Radiation resistance and stem-like cells in brain tumors.

  2006cited by this paper
• Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

  2006cited by this paper
• Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.

  2005cited by this paper
• Inducible effects of icariin, icaritin, and desmethylicaritin on directional differentiation of embryonic stem cells into cardiomyocytes in vitro

  2005cited by this paper
• Endocrine therapy for advanced breast cancer: A review

  2005cited by this paper
• Transient Versus Sustained Phosphorylation and Nuclear Accumulation of ERKs Underlie Anti-Versus Pro-apoptotic Effects of Estrogens*

  2005cited by this paper
• Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.

  2005cited by this paper
• Mammary stem cells, self-renewal pathways, and carcinogenesis

  2005influential reference
• Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway.

  2004cited by this paper
• ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions

  2004cited by this paper
• Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells.

  2004influential reference
• Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis.

  2003cited by this paper
• Map kinase signaling pathways and hematologic malignancies.

  2003cited by this paper
• Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes

  2002cited by this paper
• Transient and sustained ERK phosphorylation and nuclear translocation in growth control

  2002cited by this paper
• Mechanisms of tamoxifen-induced apoptosis

  2001cited by this paper
• Mammalian MAP kinase signalling cascades

  2001cited by this paper
• Cell cycle control and cancer.

  2000cited by this paper
• Persistent Activation of ERK Contributes to Glutamate-induced Oxidative Toxicity in a Neuronal Cell Line and Primary Cortical Neuron Cultures*

  2000influential reference
• Cell cycle checkpoints and their inactivation in human cancer

  2000cited by this paper
• Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells.

  1999cited by this paper
• Mitogen-activated protein kinase pathways.

  1997cited by this paper
• The role of proteases during apoptosis

  1996cited by this paper
• Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

  1995cited by this paper
• Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

  1995cited by this paper
• Cell cycle control and cancer.

  1994cited by this paper
• Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor.

  1992cited by this paper
• A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

  1971cited by this paper

• Anti-ferroptosis: A Promising Therapeutic Approach in Nasopharyngeal Carcinoma.

  2025cites this paper
• Epimedium and its Chemical Constituents in Cancer Treatment: A Comprehensive Review of Traditional Applications, Antitumor Effects, Pharmacokinetics, Delivery Systems, and Toxicology.

  2025cites this paper
• Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment

  2025cites this paper
• Antineoplastic effects of icaritin: molecular mechanisms and applications

  2025cites this paper
• Integrated in silico and in vitro study of microwave-synthesized prenylated rutin derivatives for anticancer activity

  2025cites this paper
• Icaritin protects against airway inflammation by inhibiting the TLR4/NF-κB pathway in vivo and in vitro.

  2025cites this paper
• Design, synthesis and evaluation of carbamate-bridged amino acid prodrugs of cycloicaritin with improved antitumor activity, aqueous solubility and phase II metabolic stability.

  2024cites this paper
• In Vitro evaluation of the anti-pancreatic cancer activity of epimedium herb

  2024cites this paper
• N-Ethyl-N-Nitrosourea Induced Leukaemia in a Mouse Model: Protective Effect of Icaritin via Inhibition of IL-6/JAK2/STAT3 Pathway Causes Apoptosis

  2024cites this paper
• Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives.

  2024cites this paper
• Lactoferrin targeting INTL1 receptor inhibits hepatocellular carcinoma progression via apoptosis and cell cycle signaling pathways

  2024cites this paper
• Phytochemicals as Novel Therapeutics for Triple‐Negative Breast Cancer: A Comprehensive Review of Current Knowledge

  2024influential citation
• A systematic review of the botany, traditional uses, phytochemistry and pharmacology of Epimedium

  2024cites this paper
• Bioinformatic analysis of neuropeptide related genes in patients diagnosed with invasive breast carcinoma

  2024cites this paper
• Comprehensive review of the traditional uses and the potential benefits of epimedium folium

  2024cites this paper
• Icaritin induces resolution of inflammation by targeting cathepsin B to prevents mice from ischemia-reperfusion injury

  2023cites this paper
• A Review of the Synthesis and Biological Activity of Flavonoid Mannich Base Derivatives

  2023cites this paper
• [Icaritin increases radiosensitivity of nasopharyngeal carcinoma cells by regulating iron death].

  2023cites this paper
• UHPLC-ESI-QE-Orbitrap-MS based metabolomics reveals the antioxidant mechanism of icaritin on mice with cerebral ischemic reperfusion

  2023cites this paper
• Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma

  2023cites this paper
• Natural STAT3 inhibitors for cancer treatment: A Comprehensive Literature Review.

  2023cites this paper
• Icaritin: A phytomolecule with enormous pharmacological values.

  2023cites this paper
• Case report: A case study on the treatment using icaritin soft capsules in combination with lenvatinib achieving impressive PR and stage reduction in unresectable locally progressive pancreatic cancer and a literature review

  2023cites this paper
• Potato protease inhibitors, a functional food material with antioxidant and anticancer potential

  2023cites this paper
• The location of estrogen receptor variant ER-α36 is associated with the invasion of glioblastoma.

  2023cites this paper
• Icaritin Derivative IC2 Induces Cytoprotective Autophagy of Breast Cancer Cells via SCD1 Inhibition

  2023cites this paper
• Icaritin Inhibits Migration and Invasion of Human Ovarian Cancer Cells via the Akt/mTOR Signaling Pathway

  2022cites this paper
• Icaritin inhibits oxidative stress in murine astrocytes by binding to Orai1 to block store‐operated calcium channel

  2022cites this paper
• Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

  2022cites this paper
• Icariin as an emerging candidate drug for anticancer treatment: Current status and perspective.

  2022cites this paper
• Icaritin induces apoptosis and downregulates RhoA/ROCK pathway in the A549 adenocarcinoma cell line

  2022cites this paper
• Co-Immobilizing Two Glycosidases Based on Cross-Linked Enzyme Aggregates to Enhance Enzymatic Properties for Achieving High Titer Icaritin Biosynthesis.

  2022cites this paper
• Identification of icaritin derivative IC2 as an SCD-1 inhibitor with anti-breast cancer properties through induction of cell apoptosis

  2022cites this paper
• Resibufogenin Targets the ATP1A1 Signaling Cascade to Induce G2/M Phase Arrest and Inhibit Invasion in Glioma

  2022cites this paper
• Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime

  2022cites this paper
• A novel α-L-Rhamnosidase renders efficient and clean production of icaritin

  2022cites this paper
• Natural Products as a Promising Therapeutic Strategy to Target Cancer Stem Cells.

  2021cites this paper
• Systems pharmacology dissection of Epimedium targeting tumor microenvironment to enhance cytotoxic T lymphocyte responses in lung cancer

  2021cites this paper
• Flavonoids Targeting Cancer Stem Cells: A Paradigm to Anticancer Efficacy

  2021cites this paper
• Screening and characterization of a GH78 α-l-rhamnosidase from Aspergillus terreus and its application in the bioconversion of icariin to icaritin with recombinant β-glucosidase.

  2021cites this paper
• A Low Dose of Hydrous Icaritin Nano-Formulation with Remarkable Efficacy and Tumor Targeting in Cancer Therapy.

  2021cites this paper
• ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer

  2021cites this paper
• Icariin induces apoptosis in breast cancer MCF-7 cells by regulating the MELK mediated PI3K/AKT signaling pathway

  2021cites this paper
• Bioactive Compounds from Herbal Medicine Targeting Multiple Myeloma

  2021cites this paper
• Biotransformation of the total flavonoid extract of epimedium into icaritin by two thermostable glycosidases from Dictyoglomus thermophilum DSM3960

  2021cites this paper
• Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma

  2021cites this paper
• Nanocarriers in the Enhancement of Therapeutic Efficacy of Natural Drugs

  2021cites this paper
• Prenylated flavonoids in foods and their applications on cancer prevention

  2021cites this paper
• Immobilization of Thermostable β-Glucosidase and α-l-Rhamnosidase from Dictyoglomus thermophilum DSM3960 and Their Cooperated Biotransformation of Total Flavonoids Extract from Epimedium into Icaritin

  2021cites this paper
• Biochemical characterization of a novel hyperthermophilic α-l-rhamnosidase from Thermotoga petrophila and its application in production of icaritin from epimedin C with a thermostable β-glucosidase

  2020cites this paper
• Natural product-derived icaritin exerts anti-glioblastoma effects by positively modulating estrogen receptor β

  2020cites this paper
• The role of ERα36 in cell type-specific functions of estrogen and cancer development.

  2020cites this paper
• Selective alkylation of β-anhydroicaritine and their biological evaluation on anticancer

  2020cites this paper
• Natural and herbal compounds targeting breast cancer, a review based on cancer stem cells

  2020influential citation
• STAT3 transcription factor as target for anti-cancer therapy

  2020cites this paper
• A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods

  2020cites this paper
• Icaritin activates Nrf2/Keap1 signaling to protect neuronal cells from oxidative stress

  2020cites this paper
• Hydrous icaritin nanorods with excellent stability improves the in vitro and in vivo activity against breast cancer

  2020influential citation
• Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy

  2019cites this paper
• UPLC–ESI-PDA–Msn Profiling Of Phenolics Involved In Biological Activities Of The Medicinal Plant Halocnemum Strobilaceum (Pall.)

  2019cites this paper
• Identification of Quinone Methide Intermediate Resulting from Metabolic Activation of Icaritin in Vitro and in Vivo.

  2019cites this paper
• Epimedium koreanum Extract and Its Flavonoids Reduced Atherosclerotic Risk via Suppressing Modification of Human HDL

  2019cites this paper
• Overexpressed IGFBP5 promotes cell proliferation and inhibits apoptosis of nucleus pulposus derived from rats with disc degeneration through inactivating the ERK/MAPK axis

  2019cites this paper
• Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells

  2019cites this paper
• Improved Synthesis of Icaritin and Total Synthesis of β-Anhydroicaritin

  2019cites this paper
• C-prenylated flavonoids with potential cytotoxic activity against solid tumor cell lines

  2019cites this paper
• Icariin induces apoptosis of human lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway.

  2019cites this paper
• Down-regulation of microRNA-10a mediates the anti-tumor effect of icaritin in A549 cells via the PTEN/AKT and ERK pathway.

  2019cites this paper
• Improvement of icaritin on hematopoietic function in cyclophosphamide-induced myelosuppression mice

  2018cites this paper
• Icaritin induces ovarian cancer cell apoptosis through activation of p53 and inhibition of Akt/mTOR pathway

  2018cites this paper
• Epimedium elatum (Morr & Decne): A Therapeutic Medicinal Plant from Northwestern Himalayas of India

  2018cites this paper
• Reactive oxygen species induced by icaritin promote DNA strand breaks and apoptosis in human cervical cancer cells

  2018cites this paper
• Effects of Icaritin on the physiological activities of esophageal cancer stem cells.

  2018cites this paper
• Activation of PPARγ mediates icaritin-induced cell cycle arrest and apoptosis in glioblastoma multiforme.

  2018cites this paper
• Development of Fluorescence-Linked Immunosorbent Assay for Icariin

  2017cites this paper
• Icaritin induces MC3T3-E1 subclone14 cell differentiation through estrogen receptor-mediated ERK1/2 and p38 signaling activation.

  2017cites this paper
• Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling

  2017cites this paper
• AMPK-autophagy inhibition sensitizes icaritin-induced anti-colorectal cancer cell activity

  2017cites this paper
• Anhydroicaritin, a SREBPs inhibitor, inhibits RANKL‐induced osteoclastic differentiation and improves diabetic osteoporosis in STZ‐induced mice

  2017cites this paper
• Effect of drying processes on prenylflavonoid content and antioxidant activity of Epimedium koreanum Nakai

  2017cites this paper
• A sensitive and specific indirect competitive enzyme‑linked immunosorbent assay for the detection of icariin.

  2017cites this paper
• Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells

  2017cites this paper
• Synthesis of prenylated flavonols and their potents as estrogen receptor modulator

  2017cites this paper
• Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.

  2017influential citation
• The Anti-Inflammatory Effect and Structure of EPCP1-2 from Crypthecodinium cohnii via Modulation of TLR4-NF-κB Pathways in LPS-Induced RAW 264.7 Cells

  2017cites this paper
• Potential of Icariin Metabolites from Epimedium koreanum Nakai as Antidiabetic Therapeutic Agents

  2017cites this paper
• Multi-Dimensional Spectrum-Effect Relationship of the Impact of Chinese Herbal Formula Lichong Shengsui Yin on Ovarian Cancer

  2017cites this paper
• Protective effect of icaritin on focal cerebral ischemic–reperfusion mice

  2017cites this paper
• Dynamic Biodistribution of Icaritin and Its Phase-II Metabolite in Rat Tissues by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry

  2016cites this paper
• Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation.

  2016cites this paper
• A novel anticancer agent SNG1153 inhibits growth of lung cancer stem/progenitor cells

  2016cites this paper
• Icaritin, a novel FASN inhibitor, exerts anti-melanoma activities through IGF-1R/STAT3 signaling

  2016cites this paper
• Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells

  2016cites this paper
• Cancer stem cells and chemoresistance: The smartest survives the raid.

  2016cites this paper
• Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives

  2016cites this paper
• Pharmacology and Clinical Application of Plants in Epimedium L.

  2016cites this paper
• Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy.

  2016cites this paper
• Synthesis of Icaritin and β-anhydroicaritin Mannich Base Derivatives and Their Cytotoxic Activities on Three Human Cancer Cell Lines.

  2016cites this paper
• Anticancer effect of icaritin inhibits cell growth of colon cancer through reactive oxygen species, Bcl-2 and cyclin D1/E signaling.

  2016cites this paper
• Icaritin Sensitizes Human Glioblastoma Cells to TRAIL-Induced Apoptosis

  2015cites this paper